RNA sequencing of OSCC identified TGF-β-induced p-EMT as a potential therapeutic target because TB cells express factors involved in TGF-β signaling and TB represents a transition to p-EMT phenotype [51]. The gene discussed is TGFB1; the disease is tuberculosis.